IL6 and cardiomyopathy: The potential of TNF-α, IL-1β, and IL-6 as biomarkers for patients with sepsis has been proposed, and the combined test of the three has an excellent predictive value in individuals with sepsis-induced cardiomyopathy [47, 48].